Effect of Breastfeeding on Maternal and Child Health Outcomes
Conditions
Keywords
Breastfeeding, Child Health, Obesity, Blood Pressure, Asthma, Cognitive Development, Behavior, Eczema, Lung Function, Spirometry
Brief summary
The overall goal of the PROBIT study is to investigate the influence of a randomized breastfeeding promotion intervention designed to increase the duration and exclusivity of breastfeeding (the breastfeeding promotion intervention) on the development of maternal and child health outcomes. The hypothesis is that randomization to the intervention will be associated with lower child adiposity, lower risk of asthma and atopy, improved lung function, and improved cognitive outcomes.
Interventions
Breastfeeding promotion and support according to the World Health Organization's Baby Friendly Hospital Initiative
Sponsors
Study design
Eligibility
Inclusion criteria
* Birth at one of 34 Maternity Hospitals in Republic of Belarus * Breastfeeding initiated at birth, with no contraindications to breastfeeding * Apgar score \>=5 at 5 minutes * Full term gestation * Birth weight \> 2500g
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Gastrointestinal tract infection | 12 months of age | Occurrence of 1 or more episodes of gastrointestinal tract infection |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Child adiposity | Throughout childhood | — |
| asthma | 6.5 and 16 years | — |
| cognition | 6.5 and 16 years | — |
| dental caries | 6.5 years | — |
| child behavior | 6.5 years | — |
| vision | 16 years | — |
| lung function | 16 years | — |
| IGF-1 | Age 11.5 years | IGF from dried bloodspots |
| child height | throughout childhood | Research measures of length/height |
| adiponectin | age 11.5 years | adiponectin from dried bloodspot |
| Apo A1 | Child age 11.5 years | Apo A1 in dried bloodspots |
| Maternal adiposity | 6.5 and 11.5 years postpartum | — |
| insulin | child age 11.5 years | insulin measured on dried blood spots |
| Apo B | Child age 11.5 years | Apo B measured in dried blood spots |
| Child blood pressure | throughout childhood | Research measures of blood pressure at ages 6.5, 11.5 and 16 years |
| Maternal blood pressure | 11.5 years postpartum | Research measure of maternal blood pressure |
| Child metabolic syndrome | Age 11.5 years | — |
| Child growth | Throughout childhood | Growth in weight, length, weight for length, BMI, and other measures |
| Respiratory tract infections | to age 12 months and throughout childhood | Number of respiratory infections, from review of medical record |
| Atopic Eczema | Throughout childhood | Eczema from review of medical record, parent report,and direct examination |
| Atopy | Age 6.5 years | Skinprick tests for allergy |
| Eating Attitudes | Age 11.5 years | Children's Eating Attitudes Test (ChEAT) Questionnaire |
| glucose | child age 11.5 years | fingerstick glucose measured by glucometer |
Countries
Belarus